Search

Your search keyword '"Mastocytosis diagnosis"' showing total 652 results

Search Constraints

Start Over You searched for: Descriptor "Mastocytosis diagnosis" Remove constraint Descriptor: "Mastocytosis diagnosis"
652 results on '"Mastocytosis diagnosis"'

Search Results

201. Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models.

202. Generalized pruritus relieved by NSAIDs in the setting of mast cell activation syndrome.

203. An unexpected association of hematologic malignancies.

204. [Hypersensitivity to non-steroidal anti-inflammatory drugs, food allergy and mast cell activation syndrome: Relevance of the full allergy testing panel and a brief review of the subject, including two clinical case reports].

205. Mast cell deposition and activation may be a new explanation for epiploic appendagitis.

206. Treatment of refractory mastocytic enterocolitis with budesonide.

207. Inter- and intra-rater reliability and agreement in determining subcutaneous tumour margins in dogs.

209. Mastocytosis: Moving the Field to Precision and Personalized Medicine.

210. Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence.

211. New Insights into Clonal Mast Cell Disorders Including Mastocytosis.

212. Bone Marrow Expression of Mast Cell Disorders.

213. Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis.

214. Gastrointestinal Involvement in Mast Cell Activation Disorders.

215. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.

216. Development and validation of the mastocytosis activity score.

218. Mast cell disorders: Protean manifestations and treatment responses.

219. Mast Cell Activation Syndrome Mimicking Breast Cancer: Case Report With Pathophysiologic Considerations.

220. Mast Cell Activation Syndrome.

221. Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila.

222. Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.

224. Vulvar Nodules: A Rare Presentation of Mastocytosis.

225. Treatment outcomes and prognostic factors of feline splenic mast cell tumors: A multi-institutional retrospective study of 64 cases.

226. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.

227. Variability of PD-L1 expression in mastocytosis.

228. The Possible Role of Gene Variant Coding Nonfunctional Toll-Like Receptor 2 in the Pathogenesis of Mastocytosis.

229. Lymph Node Haematopoietic, Histiocytic, Dendritic Proliferations and Other Lymphoid Organs.

230. Mastocytosis: a case series of 107 consecutive patients.

231. Fatigue is common and severe in patients with mastocytosis.

232. Mastozytose - Pathogenese, Klinik und Therapie.

233. Pretreatment leukocyte ratios and concentrations as predictors of outcome in dogs with cutaneous mast cell tumours.

234. Mast Cell Disease Assessment by Flow Cytometric Analysis.

235. Mast Cell Activation Syndrome.

236. What is your diagnosis? Purple granules within neutrophils of a dog.

237. Natural history and treatment of cutaneous and systemic mastocytosis.

238. Hymenoptera-induced anaphylaxis: is it a mast cell driven hematological disorder?

239. Mast Cell Disorders, Melanoma and Pancreatic Carcinoma: From a Clinical Observation to a Brief Review of the Literature.

240. Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing.

241. Anaplastic mast cell sarcoma: a unique pathologic entity in mastocytosis.

242. Tryptase Increase without Mastocytosis or Anaphylaxis.

243. Successful Management of a Patient With Possible Mast Cell Activation Syndrome Undergoing Pulmonary Embolectomy: A Case Report.

244. Vaccination management in children and adults with mastocytosis.

245. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.

246. Characterization of Mast Cell Activation Syndrome.

247. [Mastocytosis : Clinical aspects, diagnostics, therapy].

248. Chemotherapy in Mastocytosis: Administration Issues, Hypersensitivity, and Rapid Drug Desensitization.

249. An unusual case of tubulointerstitial renal mastocytosis.

250. Clinical Pearls.

Catalog

Books, media, physical & digital resources